TF and neoplasm: In vivo studies have demonstrated that the administrated TiO2-Tf–Tc prefer to accumulate in the tumor tissue and that the co-administration of TiO2-Tf–Tc and radionuclides efficiently inhibited the tumor growth and increased the median survival.